A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation
- 31 October 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (9) , 587-591
- https://doi.org/10.1038/sj.bmt.1703694
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 19 references indexed in Scilit:
- Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2001
- Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueBritish Journal of Haematology, 2000
- Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphomaBone Marrow Transplantation, 2000
- Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationBone Marrow Transplantation, 1999
- Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositisBone Marrow Transplantation, 1998
- Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyBone Marrow Transplantation, 1998
- Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantationBone Marrow Transplantation, 1997
- Effects of chlorhexidine during immunosuppressive chemotherapy: A preliminary reportOral Surgery, Oral Medicine, Oral Pathology, 1993
- Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantationOral Surgery, Oral Medicine, Oral Pathology, 1992
- Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation studyEuropean Journal of Cancer and Clinical Oncology, 1984